结直肠癌患者肿瘤干细胞标志物LGR5的临床病理及预后意义

IF 2.7 Q3 ONCOLOGY Colorectal Cancer Pub Date : 2019-11-12 DOI:10.2217/crc-2019-0009
Chukwuemeka Ihemelandu, Aisha Naeem, Erika Parasido, Deborah Berry, Krysta Chaldekas, Brent T Harris, Olga Rodriguez, Christopher Albanese
{"title":"结直肠癌患者肿瘤干细胞标志物LGR5的临床病理及预后意义","authors":"Chukwuemeka Ihemelandu,&nbsp;Aisha Naeem,&nbsp;Erika Parasido,&nbsp;Deborah Berry,&nbsp;Krysta Chaldekas,&nbsp;Brent T Harris,&nbsp;Olga Rodriguez,&nbsp;Christopher Albanese","doi":"10.2217/crc-2019-0009","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To analyze the clinicopathologic and prognostic significance of Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), a cancer stem cell marker expression in a cohort of colorectal cancer patients (CRC).</p><p><strong>Patients & methods: </strong>A total of 76 formalin-fixed paraffin-embedded tissue blocks of primary or metastatic tumors from 49 CRC patients were collected for duration 2009-2015. LGR5 expression was assessed through immunohistochemical staining of a tissue microarray.</p><p><strong>Results: </strong>LGR5 was significantly over expressed in CRC tissue samples and found to be a statistically significant independent prognostic marker for an improved overall survival.</p><p><strong>Conclusion: </strong>LGR5 expression was higher in colorectal cancer than in normal tissue. LGR5 was an independent prognostic marker for better clinical outcomes and might be used as a potential therapeutic target in CRCs.</p>","PeriodicalId":43638,"journal":{"name":"Colorectal Cancer","volume":"8 4","pages":"CRC11"},"PeriodicalIF":2.7000,"publicationDate":"2019-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/crc-2019-0009","citationCount":"8","resultStr":"{\"title\":\"Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer.\",\"authors\":\"Chukwuemeka Ihemelandu,&nbsp;Aisha Naeem,&nbsp;Erika Parasido,&nbsp;Deborah Berry,&nbsp;Krysta Chaldekas,&nbsp;Brent T Harris,&nbsp;Olga Rodriguez,&nbsp;Christopher Albanese\",\"doi\":\"10.2217/crc-2019-0009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aim: </strong>To analyze the clinicopathologic and prognostic significance of Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), a cancer stem cell marker expression in a cohort of colorectal cancer patients (CRC).</p><p><strong>Patients & methods: </strong>A total of 76 formalin-fixed paraffin-embedded tissue blocks of primary or metastatic tumors from 49 CRC patients were collected for duration 2009-2015. LGR5 expression was assessed through immunohistochemical staining of a tissue microarray.</p><p><strong>Results: </strong>LGR5 was significantly over expressed in CRC tissue samples and found to be a statistically significant independent prognostic marker for an improved overall survival.</p><p><strong>Conclusion: </strong>LGR5 expression was higher in colorectal cancer than in normal tissue. LGR5 was an independent prognostic marker for better clinical outcomes and might be used as a potential therapeutic target in CRCs.</p>\",\"PeriodicalId\":43638,\"journal\":{\"name\":\"Colorectal Cancer\",\"volume\":\"8 4\",\"pages\":\"CRC11\"},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2019-11-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/crc-2019-0009\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Colorectal Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/crc-2019-0009\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Colorectal Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/crc-2019-0009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 8

摘要

目的:分析富亮氨酸重复-含g蛋白偶联受体5 (Leucine-rich repeat-containing G-protein-coupled receptor 5, LGR5)这一肿瘤干细胞标志物在结直肠癌患者(CRC)队列中的表达及其临床病理和预后意义。患者与方法:2009-2015年共收集49例结直肠癌患者原发或转移性肿瘤的76个福尔马林固定石蜡包埋组织块。通过组织芯片的免疫组织化学染色评估LGR5的表达。结果:LGR5在结直肠癌组织样本中显著过表达,是提高总生存率的一个具有统计学意义的独立预后指标。结论:LGR5在结直肠癌组织中的表达高于正常组织。LGR5是一个独立的预后指标,具有较好的临床结果,可能作为治疗crc的潜在靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Clinicopathologic and prognostic significance of LGR5, a cancer stem cell marker in patients with colorectal cancer.

Aim: To analyze the clinicopathologic and prognostic significance of Leucine-rich repeat-containing G-protein-coupled receptor 5 (LGR5), a cancer stem cell marker expression in a cohort of colorectal cancer patients (CRC).

Patients & methods: A total of 76 formalin-fixed paraffin-embedded tissue blocks of primary or metastatic tumors from 49 CRC patients were collected for duration 2009-2015. LGR5 expression was assessed through immunohistochemical staining of a tissue microarray.

Results: LGR5 was significantly over expressed in CRC tissue samples and found to be a statistically significant independent prognostic marker for an improved overall survival.

Conclusion: LGR5 expression was higher in colorectal cancer than in normal tissue. LGR5 was an independent prognostic marker for better clinical outcomes and might be used as a potential therapeutic target in CRCs.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Colorectal Cancer
Colorectal Cancer ONCOLOGY-
自引率
0.00%
发文量
0
期刊介绍: Colorectal cancer is a major cause of morbidity and mortality, particularly in the developed world. Risk factors for colorectal cancer are on the rise in many countries; populations are aging, and obesity and diabetes are increasing. National screening programs are helping to detect cancer while it is still curable; however, colorectal cancer remains the third leading cause of cancer deaths in the USA and options are still limited for those with more advanced disease. Consequently, colorectal cancer is a major research priority for government, pharmaceutical companies and non-profit organizations. Research into diagnosis and optimum treatment of the disease is progressing rapidly, with new advances reported every day. Colorectal Cancer presents reviews, analysis and commentary. on all aspects of colorectal cancer.
期刊最新文献
The role of colorectal cancer plasticity in metastasis and treatment: an interview with Mirjana Efremova Prognostic significance of the diameter of superior rectal vein for locally advanced rectal cancer Clinical and quality of life outcomes with trifluridine/tipiracil: PRECONNECT and TALLISUR studies Colorectal cancer incidence and mortality: trends from the Pennsylvania Cancer Registry across three decades Exosome-derived miRNAs regulate macrophage-colorectal cancer cell cross-talk during aggressive tumor development
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1